Form 4 holding
Chief Financial Officer
Seres Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 182,442
- Estimated value
- $197,037
- Report date
- 16 Feb 2024
- Price
- $1.08
- Ownership
- Direct
David Arkowitz - Chief Financial Officer at Seres Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- MCRB on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by David Arkowitz since 13 Sep 2025
Reported holdings for David Arkowitz in Seres Therapeutics, Inc.
Form 4 holding
Chief Financial Officer
Seres Therapeutics, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 31,875
- Estimated value
- $43,031
- Report date
- 15 Feb 2024
- Price
- $1.35
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
Seres Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 287,905
- Estimated value
- Report date
- 14 Feb 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for David Arkowitz in Seres Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.